Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

RECURSION PHARMACEUTICALS, INC.

(RXRX)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su RECURSION PHARMACEUTICALS, INC.
30/11Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Sen..
10/11Health Care Stocks Outlasting Declining Biotechs
10/11Health Care Stocks Slightly Higher Amid Market Malaise Wednesday
10/11Recursion Q3 Loss Narrows as Revenue Improves
10/11RECURSION PHARMACEUTICALS: Q3 Earnings Snapshot
10/11RECURSION PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Cond..
10/11Recursion Provides Business Updates and Reports Third Quarter 2021 Financials - Form 8-..
10/11RECURSION PHARMACEUTICALS, INC.: Results of Operations and Financial Condition, Regulatio..
10/11Recursion Provides Business Updates and Reports Third Quarter 2021 Financials
10/11Earnings Flash (RXRX) RECURSION Posts Q3 Revenue $2.5M
13/10Certain Options of Recursion Pharmaceuticals, Inc. are subject to a Lock-Up Agreement E..
13/10Certain Warrants of Recursion Pharmaceuticals, Inc. are subject to a Lock-Up Agreement ..
13/10Certain Class B Common Stock of Recursion Pharmaceuticals, Inc. are subject to a Lock-U..
07/10Health Care Stocks Ending Near Top of Thursday Leaderboard
07/10Recursion Pharmaceuticals Shares Rise 8% After Fast Track Designation
07/10RECURSION PHARMACEUTICALS: Says US FDA Grants REC-2282 Fast Track Designation for Potenti..
07/10RECURSION PHARMACEUTICALS: is Granted FDA Fast Track Designation for REC-2282 for the Pot..
07/10RECURSION PHARMACEUTICALS, INC.: Other Events, Financial Statements and Exhibits (form 8-..
07/10RECURSION: is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment..
07/10Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatmen..
29/09RECURSION PHARMACEUTICALS: Gets FDA Orphan Drug Designation for Potential Treatment of Fa..
29/09RECURSION: is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of..
29/09Recursion Gets Orphan-Drug Designation for Tumor Drug
20/09RECURSION PHARMACEUTICALS, INC.(NASD: RXRX) added to S&P Biotechnology Select Industry In..
20/09RECURSION PHARMACEUTICALS, INC.(NASD: RXRX) added to S&P Global BMI Index
09/09RECURSION PHARMACEUTICALS, INC.: Regulation FD Disclosure, Financial Statements and Exhib..
13/08RECURSION PHARMACEUTICALS: Q2 Earnings Snapshot
13/08RECURSION PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition an..
13/08RECURSION PHARMACEUTICALS: Reports Second Quarter 2021 Financials and Provides Business U..
13/08RECURSION: Reports Second Quarter 2021 Financials and Provides Business Updates
13/08RECURSION PHARMACEUTICALS: Earnings Flash (RXRX) RECURSION Posts Q2 Revenue $2.5M
13/08Recursion Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for t..
13/07RECURSION PHARMACEUTICALS: Announces Therapeutics Advisory Board, Chaired by Joseph Milet..
13/07RECURSION PHARMACEUTICALS, INC.: Regulation FD Disclosure, Financial Statements and Exhib..
13/07RECURSION: Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD
13/07Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich
12/07RECURSION: Opens Child Care Center to Support Employees
01/07RECURSION PHARMACEUTICALS: Expands Salt Lake City Headquarters
01/07RECURSION: Signs Lease With Vestar for an Additional 100,000 sf of Space at the Gateway i..
01/07Recursion Signs Lease with Vestar for an Additional 100,000 Sf of Space At the Gateway ..
23/06RECURSION PHARMACEUTICALS: Unveils Multiyear Deal With Mila for 'Tech-Enabled' Drug Disco..
23/06RECURSION PHARMACEUTICALS: Announces Multi-Year Collaboration with Mila for Tech-Enabled ..
23/06RECURSION: Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
23/06Recursion to Open Office Space Within Mila
23/06Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
21/06RECURSION PHARMACEUTICALS, INC.(NASD: RXRX) added to S&P TMI Index
15/06RECURSION PHARMACEUTICALS: to Expand in Toronto
15/06RECURSION PHARMACEUTICALS: Announces its First Major Multidisciplinary Expansion, in Toro..
15/06Recursion Announces Its First Major Multidisciplinary Expansion, in Toronto, to Further..
25/05RECURSION PHARMACEUTICALS: Starts Investigational New Drug-Enabling Studies for Potential..
25/05RECURSION PHARMACEUTICALS: Announces First Internally-Developed NCE Advanced to IND-Enabl..
25/05Recursion Pharmaceuticals, Inc. Announces First Internally-Developed NCE Advanced to IN..
14/05RECURSION PHARMACEUTICALS: Press release issued by Recursion Pharmaceuticals, Inc. dated ..
12/05RECURSION PHARMACEUTICALS: Reports Wider Q1 Loss Amid Higher Costs, Revenue Rises
12/05RECURSION PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition an..
12/05RECURSION PHARMACEUTICALS: Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Posts Q1 Reven..
12/05RECURSION PHARMACEUTICALS: Reports First Quarter 2021 Financials and Provides Business Up..
12/05Recursion Pharmaceuticals, Inc Reports Earnings Results for the First Quarter Ended Mar..
11/05RECURSION PHARMACEUTICALS: Pharma Technology Platform Could 'Disrupt' Traditional Drug Di..
21/04RECURSION PHARMACEUTICALS, INC.: Amendments to Articles of Inc. or Bylaws; Change in Fisc..
21/04RECURSION PHARMACEUTICALS: Announces Closing of Initial Public Offering
19/04RECURSION PHARMACEUTICALS, INC.(NASD: RXRX) added to NASDAQ Composite Index
16/04SECTOR UPDATE: Health Care Stocks Rising Near Friday Close
16/04UPDATE: Recursion Surges in Nasdaq Debut After Pricing IPO
16/04RECURSION PHARMACEUTICALS: Prices IPO At High End of Expected Range
16/04RECURSION PHARMACEUTICALS: Announces Pricing of Initial Public Offering
15/04Recursion Pharmaceuticals, Inc. has completed an IPO in the amount of $436.363632 milli..
22/03Recursion Pharmaceuticals, Inc. has filed an IPO in the amount of $100 million.
18/02Recursion Appoints Louisa Daniels as Its Chief Legal Officer and General Counsel
08/01Recursion Appoints Ramona Doyle as Chief Medical Officer
2020Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New ..
2020Recursion Pharmaceuticals, Inc. announced that it has received $239 million in funding ..
2020Recursion Pharmaceuticals, Inc. announced a financing transaction
2020Recursion Posts Immune Mapping and Drug Discovery Resource and Releases New Image Datas..
2020Recursion Pharmaceuticals, Inc. acquired substantially all the assets of Vium, Inc. for..
1  2Pross.